0000000000737567

AUTHOR

Giacomo Novara

showing 8 related works from this author

Risk of Virus Contamination Through Surgical Smoke During Minimally Invasive Surgery: A Systematic Review of the Literature on a Neglected Issue Revi…

2020

Abstract Context The coronavirus disease 2019 (COVID-19) pandemic raised concerns about the safety of laparoscopy due to the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diffusion in surgical smoke. Although no case of SARS-CoV-2 contagion related to surgical smoke has been reported, several international surgical societies recommended caution or even discouraged the use of a laparoscopic approach. Objective To evaluate the risk of virus spread due to surgical smoke during surgical procedures. Evidence acquisition We searched PubMed and Scopus for eligible studies, including clinical and preclinical studies assessing the presence of any virus in the surgical smoke fr…

covid-19; minimally invasive surgery; smoke; surgical; virus; covid-19; colectomy; condylomata acuminata; coronavirus infections; gastrectomy; hepatectomy; humans; laryngeal neoplasms; minimally invasive surgical procedures; pandemics; papilloma; papillomavirus infections; pneumonia; viral; risk; sars-cov-2; warts; betacoronavirus; hepatitis b virus; infectious disease transmission; patient-to-professional; laparoscopy; papillomaviridae; smokehepatitis b virusvirusesmedicine.medical_treatmentlaparoscopy030232 urology & nephrologyDiseasemedicine.disease_causeCOVID-19; Minimally invasive surgery; Surgical; Virus; smoke.Genital warts0302 clinical medicineSurgicalwartsPandemichumansriskColectomyCoronaviruscondylomata acuminataCOVID-19 Minimally invasive surgery smoke Surgical Virus Colectomy Condylomata Acuminata Coronavirus Infections Gastrectomy Hepatectomy Humans Laryngeal Neoplasms Minimally Invasive Surgical Procedures Pandemics Papilloma Papillomavirus Infections Pneumonia Viral Risk Warts Betacoronavirus Hepatitis B virus Infectious Disease Transmission Patient-to-Professional Laparoscopy Papillomaviridae SmokeTransmission (medicine)virus diseasescolectomyCOVID-19; Minimally invasive surgery; smoke; Surgical; VirusgastrectomyViruspapillomasars-cov-2030220 oncology & carcinogenesispatient-to-professionalpapillomavirus infectionsviralmedicine.medical_specialtyInfectious Disease Transmission Patient-to-Professionallaryngeal neoplasmsUrologyPneumonia ViralContext (language use)pandemicsArticle03 medical and health sciencescoronavirus infectionshepatectomyMinimally invasive surgerymedicinepneumoniaIntensive care medicinepapillomaviridaebusiness.industryCOVID-19infectious disease transmissionmedicine.diseasebetacoronavirusminimally invasive surgical proceduresPneumoniasmokebusinessEuropean Urology Focus
researchProduct

Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival

2016

Background Renal cell carcinoma forming a venous tumor thrombus (VTT) in the inferior vena cava (IVC) has a poor prognosis. Recent investigations have been focused on prognostic markers of survival. Thrombus consistency (TC) has been proposed to be of significant value but yet there are conflicting data. The aim of this study is to test the effect of IVC VTT consistency on cancer specific survival (CSS) in a multi-institutional cohort. Methods The records of 413 patients collected by the International Renal Cell Carcinoma–Venous Thrombus Consortium were retrospectively analyzed. All patients underwent radical nephrectomy and tumor thrombectomy. Kaplan–Meier estimate and Cox regression analy…

medicine.medical_specialtyProportional hazards modelbusiness.industrymedicine.medical_treatment030232 urology & nephrologyRetrospective cohort studyGeneral Medicinemedicine.diseaseInferior vena cavaNephrectomy03 medical and health sciences0302 clinical medicineOncologymedicine.veinRenal cell carcinoma030220 oncology & carcinogenesismedicineSurgeryRadiologyThrombusStage (cooking)businessSurvival analysisJournal of Surgical Oncology
researchProduct

Clinical pathways for urology patients during the COVID-19 pandemic

2020

The public health emergency caused by the Coronavirus Disease 2019 (COVID-19) pandemic has resulted in a significant reallocation of health resources with a consequent reorganization of the clinical activities also in several urological centers. A panel of Italian urologists has agreed on a set of recommendations on pathways of pre-, intra- and post-operative care for urological patients undergoing urgent procedures or non-deferrable oncological interventions during the COVID-19 pandemic. Simplification of the diagnostic and staging pathway has to be prioritized in order to reduce hospital visits and consequently the risk of contagion. In absence of strict uniform regulations that impose th…

Critical Pathways; Elective Surgical Procedures; Female; Humans; Italy; Male; Perioperative Care; Public Health; Triage; Urologic Diseases; Urologic Neoplasms; Urologic Surgical Procedures; Urologists; Coronavirus Infections; Pandemics; Pneumonia Viral; UrologyMaleUrologistscoronavirus030232 urology & nephrologyPsychological interventioncovid19clinical pandemic0302 clinical medicinePandemicMedicineViralurologyItalycovid-19Elective Surgical ProceduresNephrology030220 oncology & carcinogenesisCritical PathwaysUrologic Surgical ProceduresFemalePublic HealthtelemedicineCoronavirus InfectionsElective Surgical ProcedureUrologic DiseasesUrologic Neoplasmsmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)UrologyPneumonia ViralMEDLINECoronavirus COVID-19 Clinical pandemic Urology Practice guideline Clinical pathways TelemedicinePerioperative Careclinical pandemic; clinical pathways; coronavirus; covid-19; practice guideline; telemedicine; urology03 medical and health sciencesHumansPandemicsbusiness.industrypractice guidelinepandemicPublic healthcovid19; urology; pandemicPneumoniaTriageEmergency medicineclinical pathwaysTriagebusinessHospital stayMinerva Urologica e Nefrologica
researchProduct

Urology practice during COVID-19 pandemic

2020

The severe acute respiratory syndrome coronavirus 2 and the disease it causes, coronavirus disease 2019 (COVID-19) is generating a rapid and tragic health emergency in Italy due to the need to provide assistance to an overwhelming number of infected patients and, at the same time, treat all the non-deferrable oncological and benign conditions. A panel of Italian urologists has agreed on possible strategies for the reorganization of urological routine practice and on a set of recommendations that should facilitate the process of rescheduling both surgical and outpatient activities during the COVID-19 pandemic and in the subsequent phases. This document could be a valid tool to be used in rou…

medicine.medical_specialtyPractice guidelineInfectious Disease Transmission Patient-to-ProfessionalCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)UrologistsPneumonia Viral030232 urology & nephrologyMEDLINEcoronavirusDiseaseRoutine practicesurgery03 medical and health sciencesPatient safety0302 clinical medicineAnesthesiologyAnesthesiologyPandemicmedicineHumanscoronavirus; COVID-19; pandemics; practice guideline; surgery; urologyIntensive care medicineurologyPandemicsPatient Care Teambusiness.industrypandemicendourologyCOVID-19coronavirus; pandemic; urologyHospitalsCoronavirus COVID-19 Pandemics Urology Practice guideline SurgeryHospitalizationcoronaviruItalyNephrology030220 oncology & carcinogenesisUrologic Surgical ProceduresPatient SafetybusinessCoronavirus Infectionsclinical practice guideline
researchProduct

Impact of the COVID-19 pandemic on urological practice in emergency departments in Italy

2020

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and the disease it causes, coronavirus disease 2019 (COVID-19), are causing a rapid and tragic health emergency worldwide [1,2]. Italy was the first European country to experience a virus outbreak, starting on 21 February 2020. It resulted in a national quarantine, and the official lockdown of the country’s non-essential businesses and services began on 9 March 2020. Although several reports are available in the literature providing recommendations for the reorganization of clinical and surgical activities [3–7], to our knowledge, no data are available on the effects of the COVID-19 pandemic on the outcomes of other medical conditi…

Urologic Diseasesmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINE.SARS‐CoV‐2BetacoronavirusResearch CorrespondencePandemicmedicineSARS‐CoV‐2; coronavirus disease 2019 (COVID‐19); health emergency; urologyHumansurologyPandemicsReferral and Consultationbiologybusiness.industryViral EpidemiologySARS-CoV-2Incidence (epidemiology)IncidenceCOVID-19medicine.diseasebiology.organism_classificationPneumoniahealth emergencyItalyEmergency medicineUrologic diseasecoronavirus disease 2019 (COVID‐19)businessCoronavirus InfectionsEmergency Service HospitalCoronavirus Infections Emergency Service Hospital Humans Incidence Italy Pneumonia Viral Referral and Consultation Urologic Diseases Betacoronavirus PandemicsBetacoronavirus
researchProduct

Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-…

2016

Objectives: To investigate cancer-specific mortality and other-cause mortality in prostate cancer patients with nodal metastases. Methods: The study included 411 patients treated with radical prostatectomy and pelvic lymph node dissection for prostate cancer with lymph node metastases at 10 tertiary care centers between 1995 and 2014. Kaplan–Meier analyses were used to assess cancer-specific mortality-free survival rates at 8 years' follow up in the overall population, and after stratifying patients according to clinical and pathological parameters. Uni- and multivariable competing risk Cox regression analyses were used to assess cancer-specific mortality and other-cause mortality. Finally,…

OncologyMalemedicine.medical_treatment030232 urology & nephrologyProstate cancer0302 clinical medicineRobotic Surgical ProceduresLymph nodeeducation.field_of_studyProstatectomyMortality rateLymph NodePrognosiscancer-specific mortality competing risk analysis lymph node metastases other-cause mortality radical prostatectomylymph node metastaseDissectionmedicine.anatomical_structure030220 oncology & carcinogenesisLymphatic MetastasisLymphSurvival Analysicancer-specific mortality; competing risk analysis; lymph node metastases; other-cause mortality; radical prostatectomycancer-specific mortality; competing risk analysis; lymph node metastases; other-cause mortality; radical prostatectomy; Urologyother-cause mortalityHumanlymph node metastasesRiskmedicine.medical_specialtyRobotic Surgical ProcedurePrognosiUrologyPopulationUrologycancer-specific mortality03 medical and health sciencesInternal medicinemedicineHumanseducationcompeting risk analysiProstatectomybusiness.industryProportional hazards modelcompeting risk analysisProstatic NeoplasmsLymphatic MetastasiProstate-Specific Antigenmedicine.diseaseSurvival Analysisradical prostatectomyProstatic NeoplasmLymph Node ExcisionLaparoscopyLymph Nodesbusiness
researchProduct

Pathways for urology patients during the COVID-19 pandemic

2020

The public health emergency caused by the Coronavirus Disease 2019 (COVID-19) pandemic has resulted in a significant reallocation of health resources with a consequent reorganization of the clinical activities also in several urological centers. A panel of Italian urologists has agreed on a set of recommendations on pathways of pre-, intra- and post-operative care for urological patients undergoing urgent procedures or non-deferrable oncological interventions during the COVID-19 pandemic. Simplification of the diagnostic and staging pathway has to be prioritized in order to reduce hospital visits and consequently the risk of contagion. In absence of strict uniform regulations that impose th…

Clinical practice guidelineTelemonitoringPandemicClinical pathwayUrologyCoronaviruCOVID-19
researchProduct

Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma - Results …

2013

Objectives To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival (CSS) after recurrence in patients with renal cell carcinoma (RCC) undergoing radical nephrectomy or nephron-sparing surgery. To analyse differences in clinical and histopathological criteria between patients with early and late recurrence. Patients and Methods Of 13 107 patients with RCC from an international multicentre database, 1712 patients developed recurrence in the follow-up (FU), at a median (interquartile range) of 50.1 (25-106) months. In all, 1402 patients had recurrence at ≤5 years (Group A) and 310 patients beyond this time (Group B). Differences in clinical and histopathological…

Malerenal cell carcinomaTime FactorsTime FactorDatabases FactualPrognosiUrologyprognostic parameterearly recurrencetime to recurrencecancer-specific survivalRetrospective Studielate recurrencenephrectomyHumanscancer survivalCarcinoma Renal Cellrenal cell carcinoma (RCC); time to recurrence; early recurrence; late recurrence; prognostic parameters; cancer-specific survival; nephrectomyAgedRetrospective StudiesKidney NeoplasmMiddle Agedprognostic parametersPrognosisKidney NeoplasmsSurvival Ratecancer survival; early recurrence; late recurrence; nephrectomy; prognostic parameters; renal cell carcinomacancer-specific survival; early recurrence; late recurrence; nephrectomy; prognostic parameters; renal cell carcinoma; time to recurrenceFemaleNeoplasm Recurrence Localrenal cell carcinoma (rcc)cancer-specific survival; early recurrence; late recurrence; nephrectomy; prognostic parameters; renal cell carcinoma (rcc); time to recurrenceHuman
researchProduct